We are live on
!
Find out more
RCAMU
Rothschild & Co Asset Management US Portfolio holdings
AUM
$6.58B
1-Year Est. Return
4.5%
This Fund
S&P 500
This Quarter
Est. Return
+4.91%
1 Year Est. Return
-4.5%
3 Year Est. Return
+63.72%
5 Year Est. Return
+103.96%
10 Year Est. Return
–
AUM
$4.86B
AUM Growth
+$372M
(+8.3%)
Cap. Flow
+$181M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
14.23%
Holding
386
New
26
Increased
110
Reduced
206
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$38.7M |
| 2 |
Cisco
CSCO
|
+$37.1M |
| 3 |
Parker-Hannifin
PH
|
+$31.7M |
| 4 |
PepsiCo
PEP
|
+$30.4M |
| 5 |
AT&T
T
|
+$25.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$30.2M |
| 2 |
Norfolk Southern
NSC
|
+$22.6M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$21.6M |
| 4 |
BorgWarner
BWA
|
+$19.2M |
| 5 |
STSA
STERLING FINL CORP (WA) COM NEW
STSA
|
+$15.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 16.44% |
| 2 | Financials | 15.52% |
| 3 | Technology | 13.68% |
| 4 | Healthcare | 11.91% |
| 5 | Consumer Discretionary | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Helmerich & Payne
HP
$4.31B
| $6.15M | 0.13% |
+52,940
| New | +$5.8M |
|
|
AOL
252
DELISTED
AOL INC COMMON STOCK
AOL
| $6.02M | 0.12% |
151,205
-1,077
| -0.7% | -$42.4K |
|
253
Rockwell Automation
ROK
$46.2B
| $6.01M | 0.12% |
48,011
-93,991
| -66% | -$11.6M |
|
|
ESND
254
DELISTED
Essendant Inc.
ESND
| $5.93M | 0.12% |
143,100
-1,869
| -1% | -$73.2K |
|
|
SNDK
255
DELISTED
SANDISK CORP
SNDK
| $5.91M | 0.12% |
56,612
-23,555
| -29% | -$2.14M |
|
256
ICU Medical
ICUI
$3.9B
| $5.89M | 0.12% |
96,927
-69,614
| -42% | -$4.11M |
|
257
Cooper Companies
COO
$10.2B
| $5.85M | 0.12% |
172,568
-392
| -0.2% | -$12.9K |
|
258
Federal Signal
FSS
$6.86B
| $5.85M | 0.12% |
399,089
-2,200
| -0.5% | -$32.2K |
|
|
ORB
259
DELISTED
ORBITAL SCIENCES CORP
ORB
| $5.83M | 0.12% |
197,269
+13,418
| +7% | +$373K |
|
260
Eastman Chemical
EMN
$7.57B
| $5.81M | 0.12% |
66,536
+36,494
| +121% | +$3.17M |
|
261
RenaissanceRe
RNR
$13.6B
| $5.78M | 0.12% |
54,034
-399
| -0.7% | -$40.9K |
|
|
BECN
262
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $5.78M | 0.12% |
174,477
-390
| -0.2% | -$13.7K |
|
263
Calix
CALX
$2.25B
| $5.72M | 0.12% |
699,399
-11,853
| -2% | -$96.9K |
|
|
CEB
264
DELISTED
CEB Inc.
CEB
| $5.7M | 0.12% |
83,584
-1,420
| -2% | -$97.6K |
|
265
Ball Corp
BALL
$16.1B
| $5.68M | 0.12% |
181,170
+1,186
| +0.7% | +$34.7K |
|
266
Service Corp International
SCI
$11.1B
| $5.63M | 0.12% |
271,847
-6,192
| -2% | -$121K |
|
|
ENOC
267
DELISTED
EnerNOC, Inc.
ENOC
| $5.53M | 0.11% |
291,872
-1,884
| -0.6% | -$38K |
|
|
INSY
268
DELISTED
Insys Therapeutics, Inc.
INSY
| $5.5M | 0.11% |
351,938
-2,172
| -0.6% | -$35.1K |
|
|
AGN
269
DELISTED
Allergan plc
AGN
| $5.49M | 0.11% |
24,629
+1,171
| +5% | +$242K |
|
270
Bruker
BRKR
$8.43B
| $5.42M | 0.11% |
223,397
+34
| +0% | +$738 |
|
271
Reinsurance Group of America
RGA
$16.1B
| $5.26M | 0.11% |
66,614
-69
| -0.1% | -$5.38K |
|
272
Haverty Furniture Companies
HVT
$431M
| $5.24M | 0.11% |
208,652
-810
| -0.4% | -$20.6K |
|
273
Landstar System
LSTR
$5.84B
| $5.23M | 0.11% |
+81,684
| New | +$5.11M |
|
274
Hanmi Financial
HAFC
$952M
| $5.2M | 0.11% |
246,855
+35,034
| +17% | +$768K |
|
275
NETSCOUT
NTCT
$2.78B
| $4.97M | 0.1% |
112,077
-228
| -0.2% | -$8.86K |
|
Similar funds
GG
AIM
AAM
PG
ZCA
GJIC
SBL
TFS
Rothschild & Co Asset Management US's Q2 2014 Portfolio in Review
As of Q2 2014, Rothschild & Co Asset Management US held 386 positions worth $4.86B, up 8.3% from $4.49B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Rothschild & Co Asset Management US deployed $181M of net new capital in Q2 2014, opening 26 new positions and adding to 110 existing holdings. Its largest new stake was Merck: 710,112 shares worth $39.2M.
By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 17% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was St Jude Medical, an estimated $30.2M trimmed.
- Rothschild & Co Asset Management US's largest Q2 2014 buy was Merck: 710,112 shares worth $39.2M.
- Rothschild & Co Asset Management US added most to Cisco in Q2 2014, an estimated $37.1M increase.
- Rothschild & Co Asset Management US's biggest Q2 2014 reduction was St Jude Medical, cutting an estimated $30.2M.
- Rothschild & Co Asset Management US fully exited Norfolk Southern in Q2 2014, selling an estimated $22.6M.
- Rothschild & Co Asset Management US's ten largest holdings make up 14% of its $4.86B portfolio in Q2 2014.
- Rothschild & Co Asset Management US opened 26 new positions and closed 37 in Q2 2014.
- Rothschild & Co Asset Management US's portfolio value rose 8.3% quarter-over-quarter to $4.86B.
Based on Rothschild & Co Asset Management US's 13F filing for Q2 2014, filed 14 Aug 2014.